Literature DB >> 18758244

A-to-I RNA editing and cancer: from pathology to basic science.

Angela Gallo1, Silvia Galardi.   

Abstract

In eukaryotes mRNA transcripts are extensively processed by different post-transcriptional events such as alternative splicing and RNA editing in order to generate many different mRNAs from the same gene, increasing the transcriptome and then the proteome. The most frequent RNA editing mechanism in mammals involves the conversion of specific adenosines into inosines by the ADAR family of enzymes. This editing event can change both the sequence and the secondary structure of RNA molecules, with important consequences on both the final proteins and regulatory RNAs. Alteration in RNA editing has been connected to numerous human pathologies and recent studies have demonstrated its importance in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758244     DOI: 10.4161/rna.5.3.6739

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  34 in total

1.  Accurate identification of A-to-I RNA editing in human by transcriptome sequencing.

Authors:  Jae Hoon Bahn; Jae-Hyung Lee; Gang Li; Christopher Greer; Guangdun Peng; Xinshu Xiao
Journal:  Genome Res       Date:  2011-09-29       Impact factor: 9.043

Review 2.  Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.

Authors:  Jean-François Gélinas; Guerline Clerzius; Eileen Shaw; Anne Gatignol
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas.

Authors:  Bin Yang; Peishan Hu; Xihua Lin; Wei Han; Liyuan Zhu; Xiaochao Tan; Fei Ye; Guanzhou Wang; Fan Wu; Bin Yin; Zhaoshi Bao; Tao Jiang; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  Cell Mol Life Sci       Date:  2015-06-06       Impact factor: 9.261

4.  A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.

Authors:  Masataka Nakano; Tatsuki Fukami; Saki Gotoh; Miki Nakajima
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

5.  Analysis and design of RNA sequencing experiments for identifying RNA editing and other single-nucleotide variants.

Authors:  Jae-Hyung Lee; Jason K Ang; Xinshu Xiao
Journal:  RNA       Date:  2013-04-18       Impact factor: 4.942

Review 6.  Molecular diversity through RNA editing: a balancing act.

Authors:  Sanaz Farajollahi; Stefan Maas
Journal:  Trends Genet       Date:  2010-04-13       Impact factor: 11.639

7.  Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells.

Authors:  Yukti Choudhury; Felix Chang Tay; Dang Hoang Lam; Edwin Sandanaraj; Carol Tang; Beng-Ti Ang; Shu Wang
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

8.  There is a world beyond protein mutations: the role of non-coding RNAs in melanomagenesis.

Authors:  Rolf K Swoboda; Meenhard Herlyn
Journal:  Exp Dermatol       Date:  2013-03-12       Impact factor: 3.960

9.  Individual RNA base recognition in immobilized oligonucleotides using a protein nanopore.

Authors:  Mariam Ayub; Hagan Bayley
Journal:  Nano Lett       Date:  2012-10-19       Impact factor: 11.189

Review 10.  Dynamic regulation of RNA editing of ion channels and receptors in the mammalian nervous system.

Authors:  Bao Zhen Tan; Hua Huang; Runyi Lam; Tuck Wah Soong
Journal:  Mol Brain       Date:  2009-05-29       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.